771 related articles for article (PubMed ID: 21630234)
1. Muscle pathology in myotonic dystrophy: light and electron microscopic investigation in eighteen patients.
Nadaj-Pakleza A; Lusakowska A; Sułek-Piątkowska A; Krysa W; Rajkiewicz M; Kwieciński H; Kamińska A
Folia Morphol (Warsz); 2011 May; 70(2):121-9. PubMed ID: 21630234
[TBL] [Abstract][Full Text] [Related]
2. A non-DM1, non-DM2 multisystem myotonic disorder with frontotemporal dementia: phenotype and suggestive mapping of the DM3 locus to chromosome 15q21-24.
Le Ber I; Martinez M; Campion D; Laquerrière A; Bétard C; Bassez G; Girard C; Saugier-Veber P; Raux G; Sergeant N; Magnier P; Maisonobe T; Eymard B; Duyckaerts C; Delacourte A; Frebourg T; Hannequin D
Brain; 2004 Sep; 127(Pt 9):1979-92. PubMed ID: 15215218
[TBL] [Abstract][Full Text] [Related]
3. Muscle pathology in 57 patients with myotonic dystrophy type 2.
Schoser BG; Schneider-Gold C; Kress W; Goebel HH; Reilich P; Koch MC; Pongratz DE; Toyka KV; Lochmüller H; Ricker K
Muscle Nerve; 2004 Feb; 29(2):275-81. PubMed ID: 14755494
[TBL] [Abstract][Full Text] [Related]
4. Type 2 myotonic dystrophy can be predicted by the combination of type 2 muscle fiber central nucleation and scattered atrophy.
Bassez G; Chapoy E; Bastuji-Garin S; Radvanyi-Hoffman H; Authier FJ; Pellissier JF; Eymard B; Gherardi RK
J Neuropathol Exp Neurol; 2008 Apr; 67(4):319-25. PubMed ID: 18379436
[TBL] [Abstract][Full Text] [Related]
5. Analysis of MTMR1 expression and correlation with muscle pathological features in juvenile/adult onset myotonic dystrophy type 1 (DM1) and in myotonic dystrophy type 2 (DM2).
Santoro M; Modoni A; Masciullo M; Gidaro T; Broccolini A; Ricci E; Tonali PA; Silvestri G
Exp Mol Pathol; 2010 Oct; 89(2):158-68. PubMed ID: 20685272
[TBL] [Abstract][Full Text] [Related]
6. Severity, type, and distribution of myotonic discharges are different in type 1 and type 2 myotonic dystrophy.
Logigian EL; Ciafaloni E; Quinn LC; Dilek N; Pandya S; Moxley RT; Thornton CA
Muscle Nerve; 2007 Apr; 35(4):479-85. PubMed ID: 17230537
[TBL] [Abstract][Full Text] [Related]
7. Hyper-CK-emia as the sole manifestation of myotonic dystrophy type 2.
Merlini L; Sabatelli P; Columbaro M; Bonifazi E; Pisani V; Massa R; Novelli G
Muscle Nerve; 2005 Jun; 31(6):764-7. PubMed ID: 15704146
[TBL] [Abstract][Full Text] [Related]
8. Histopathological differences of myotonic dystrophy type 1 (DM1) and PROMM/DM2.
Vihola A; Bassez G; Meola G; Zhang S; Haapasalo H; Paetau A; Mancinelli E; Rouche A; Hogrel JY; Laforêt P; Maisonobe T; Pellissier JF; Krahe R; Eymard B; Udd B
Neurology; 2003 Jun; 60(11):1854-7. PubMed ID: 12796551
[TBL] [Abstract][Full Text] [Related]
9. Muscleblind-like protein 1 nuclear sequestration is a molecular pathology marker of DM1 and DM2.
Cardani R; Mancinelli E; Rotondo G; Sansone V; Meola G
Eur J Histochem; 2006; 50(3):177-82. PubMed ID: 16920640
[TBL] [Abstract][Full Text] [Related]
10. Absence of a differentiation defect in muscle satellite cells from DM2 patients.
Pelletier R; Hamel F; Beaulieu D; Patry L; Haineault C; Tarnopolsky M; Schoser B; Puymirat J
Neurobiol Dis; 2009 Oct; 36(1):181-90. PubMed ID: 19632331
[TBL] [Abstract][Full Text] [Related]
11. A role for PLCβ1 in myotonic dystrophies type 1 and 2.
Faenza I; Blalock W; Bavelloni A; Schoser B; Fiume R; Pacella S; Piazzi M; D'Angelo A; Cocco L
FASEB J; 2012 Jul; 26(7):3042-8. PubMed ID: 22459146
[TBL] [Abstract][Full Text] [Related]
12. Unusual clinical, laboratory, and muscle histopathological findings in a family with myotonic dystrophy type 2.
Toth C; Dunham C; Suchowersky O; Parboosingh J; Brownell K
Muscle Nerve; 2007 Feb; 35(2):259-64. PubMed ID: 17068784
[TBL] [Abstract][Full Text] [Related]
13. Clinical aspects, molecular pathomechanisms and management of myotonic dystrophies.
Meola G
Acta Myol; 2013 Dec; 32(3):154-65. PubMed ID: 24803843
[TBL] [Abstract][Full Text] [Related]
14. Alternative splicing of human insulin receptor gene (INSR) in type I and type II skeletal muscle fibers of patients with myotonic dystrophy type 1 and type 2.
Santoro M; Masciullo M; Bonvissuto D; Bianchi ML; Michetti F; Silvestri G
Mol Cell Biochem; 2013 Aug; 380(1-2):259-65. PubMed ID: 23666741
[TBL] [Abstract][Full Text] [Related]
15. Preferential central nucleation of type 2 myofibers is an invariable feature of myotonic dystrophy type 2.
Pisani V; Panico MB; Terracciano C; Bonifazi E; Meola G; Novelli G; Bernardi G; Angelini C; Massa R
Muscle Nerve; 2008 Nov; 38(5):1405-1411. PubMed ID: 18816606
[TBL] [Abstract][Full Text] [Related]
16. Proximal myotonic myopathy: clinical, neuropathologic, and molecular genetic features.
Eisenschenk S; Triggs WJ; Pearl GS; Rojiani AM
Ann Clin Lab Sci; 2001 Apr; 31(2):140-6. PubMed ID: 11337902
[TBL] [Abstract][Full Text] [Related]
17. Cranial magnetic resonance imaging in genetically proven myotonic dystrophy type 1 and 2.
Kornblum C; Reul J; Kress W; Grothe C; Amanatidis N; Klockgether T; Schröder R
J Neurol; 2004 Jun; 251(6):710-4. PubMed ID: 15311347
[TBL] [Abstract][Full Text] [Related]
18. Comparative transcriptional and biochemical studies in muscle of myotonic dystrophies (DM1 and DM2).
Salvatori S; Furlan S; Fanin M; Picard A; Pastorello E; Romeo V; Trevisan CP; Angelini C
Neurol Sci; 2009 Jun; 30(3):185-92. PubMed ID: 19326042
[TBL] [Abstract][Full Text] [Related]
19. Peripheral nerve involvement in myotonic dystrophy type 2 - similar or different than in myotonic dystrophy type 1?
Nojszewska M; Łusakowska A; Szmidt-Salkowska E; Gaweł M; Lipowska M; Sułek A; Krysa W; Rajkiewicz M; Seroka A; Kaczmarek K; Kamińska AM
Neurol Neurochir Pol; 2015; 49(3):164-70. PubMed ID: 26048604
[TBL] [Abstract][Full Text] [Related]
20. Immortalized human myotonic dystrophy muscle cell lines to assess therapeutic compounds.
Arandel L; Polay Espinoza M; Matloka M; Bazinet A; De Dea Diniz D; Naouar N; Rau F; Jollet A; Edom-Vovard F; Mamchaoui K; Tarnopolsky M; Puymirat J; Battail C; Boland A; Deleuze JF; Mouly V; Klein AF; Furling D
Dis Model Mech; 2017 Apr; 10(4):487-497. PubMed ID: 28188264
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
